Rachel started off as a general news reporter 20 years ago before serving stints as the bureau chief for AFX News in Kuala Lumpur, Singapore and Hong Kong and finally as an editor in London. She has also worked at APM Health Europe, Chemical Watch and IBTimes UK.
“We look forward to initiating a doublet study of PTI-801 and PTI-808 in CF subjects and progressing towards a triple combination study in CF subjects in 2018” - Meenu Chhabra, president and CEO
"Beyond the high response rates previously reported with GMI-1271, we can now point to additional long-term endpoints that further support our plan to move the drug candidate into a Phase 3 clinical trial scheduled to begin in mid-2018"
The company also said it had entered into a US$150mln accelerated stock buyback deal last month
Optum health-services arm has been building up its physician practices, clinics and surgery centers over the years
Kidney cancer is one of the top 10 most common forms of cancer in the U.S., the company said
The latest approval makes the brand the first and only neurotoxin to be indicated for three facial treatment areas
"Our Medtronic Diabetes team will work as quickly as possible to complete all exchanges to the new and enhanced set and fully support our customers throughout this process," said Francine Kaufman